Ben-Eliyahu S, Shakhar G, Shakhar K, Melamed R
Department of Psychology, Tel Aviv University, Tel Aviv, 69978, Israel.
Br J Cancer. 2000 Dec;83(12):1747-54. doi: 10.1054/bjoc.2000.1563.
Clinical observations suggest that the rate of metastatic development and long-term mortality following surgery in breast cancer patients is influenced by the menstrual phase during which surgery is conducted. The menstrual cycle is known to modulate various physiological responses and medical conditions that involve adrenergic mechanisms (e.g., asthma). Natural killer activity (NKA), an immune function controlling metastasis, is suppressed following surgery, and in vitro by adrenaline. We therefore hypothesize that the clinical observation may be partly attributable to surgery-induced adrenergic suppression of NK-dependent resistance to metastasis, a suppression that depends on menstrual phase during surgery. To test this hypothesis in rats, 140 F344 females at different phases of their oestrous cycle were injected with a beta-adrenergic agonist, metaproterenol (MP) (0.4 or 0.8 mg kg(-1), s.c.), or with vehicle, before i.v. inoculation with MADB106 tumour cells. This syngeneic mammary adenocarcinoma line metastasizes only to the lungs, and is highly sensitive to NKA. In a second experiment, the suppression of NKA by MP was studied in vitro in blood drawn at different phases of the oestrous cycle (n = 36). Finally, the effects of stress on the number and activity of NK cells were assessed along the oestrous cycle (n = 71). The findings indicate that the suppressive effects of MP on resistance to metastasis and on NKA, are significantly greater during the oestrous phase characterized by high oestradiol levels (D3/proestrus/oestrus). Similarly, NKA per cell was suppressed by stress only during this phase. In untreated animals, in which inadvertent stress was minimized, no effects of the oestrous cycle on NKA or on resistance to metastasis were evident. These findings indicate that the oestrous cycle modulates adrenergic suppression of NKA and of resistance to metastasis. The relevance of these findings to the above clinical observation, as well as that of our related findings in women from a parallel study, is discussed.
临床观察表明,乳腺癌患者手术后转移发展的速率和长期死亡率受手术时所处月经周期阶段的影响。已知月经周期可调节涉及肾上腺素能机制的各种生理反应和病症(如哮喘)。自然杀伤活性(NKA)是一种控制转移的免疫功能,在手术后会受到抑制,在体外会被肾上腺素抑制。因此,我们推测临床观察结果可能部分归因于手术诱导的肾上腺素能对NK细胞依赖性转移抗性的抑制,这种抑制取决于手术时的月经周期阶段。为了在大鼠中验证这一假设,在静脉注射MADB106肿瘤细胞之前,对140只处于动情周期不同阶段的F344雌性大鼠皮下注射β-肾上腺素能激动剂间羟异丙肾上腺素(MP)(0.4或0.8 mg·kg⁻¹)或赋形剂。这种同基因乳腺腺癌系仅转移至肺部,且对NKA高度敏感。在第二项实验中,研究了MP在体外对动情周期不同阶段采集的血液中NKA的抑制作用(n = 36)。最后,评估了应激在动情周期中对NK细胞数量和活性的影响(n = 71)。研究结果表明,MP对转移抗性和NKA的抑制作用在以高雌二醇水平为特征的动情期(D3/动情前期/动情期)显著更强。同样,仅在此阶段应激会抑制单个细胞的NKA。在无意中应激最小化的未处理动物中,未发现动情周期对NKA或转移抗性有影响。这些研究结果表明,动情周期可调节肾上腺素能对NKA和转移抗性的抑制作用。讨论了这些研究结果与上述临床观察的相关性,以及我们在一项平行研究中对女性的相关研究结果的相关性。